List of Tables
Table 1. Global Inhaled Asthma Medications Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Inhaled Asthma Medications Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Inhaled Asthma Medications Market Competitive Situation by Manufacturers in 2025
Table 4. Global Inhaled Asthma Medications Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Inhaled Asthma Medications Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Inhaled Asthma Medications Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Inhaled Asthma Medications Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Inhaled Asthma Medications Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Inhaled Asthma Medications, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Inhaled Asthma Medications, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Inhaled Asthma Medications, Product Types and Applications
Table 12. Global Key Manufacturers of Inhaled Asthma Medications, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inhaled Asthma Medications Companies by Tier (Tier 1, Tier 2, Tier 3), based on Inhaled Asthma Medications Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inhaled Asthma Medications Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Inhaled Asthma Medications Sales by Region (K Units), 2021–2026
Table 18. Global Inhaled Asthma Medications Sales Market Share by Region (2021–2026)
Table 19. Global Inhaled Asthma Medications Sales by Region (K Units), 2027–2032
Table 20. Global Inhaled Asthma Medications Sales Market Share by Region (2027–2032)
Table 21. Global Inhaled Asthma Medications Revenue by Region (US$ Million), 2021–2026
Table 22. Global Inhaled Asthma Medications Revenue Market Share by Region (2021–2026)
Table 23. Global Inhaled Asthma Medications Revenue by Region (US$ Million), 2027–2032
Table 24. Global Inhaled Asthma Medications Revenue Market Share by Region (2027–2032)
Table 25. North America Inhaled Asthma Medications Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Inhaled Asthma Medications Sales by Country (K Units), 2021–2026
Table 27. North America Inhaled Asthma Medications Sales by Country (K Units), 2027–2032
Table 28. North America Inhaled Asthma Medications Revenue by Country (US$ Million), 2021–2026
Table 29. North America Inhaled Asthma Medications Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Inhaled Asthma Medications Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Inhaled Asthma Medications Sales by Country (K Units), 2021–2026
Table 32. Europe Inhaled Asthma Medications Sales by Country (K Units), 2027–2032
Table 33. Europe Inhaled Asthma Medications Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Inhaled Asthma Medications Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Inhaled Asthma Medications Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Inhaled Asthma Medications Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Inhaled Asthma Medications Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Inhaled Asthma Medications Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Inhaled Asthma Medications Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Inhaled Asthma Medications Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Inhaled Asthma Medications Sales by Country (K Units), 2021–2026
Table 42. Latin America Inhaled Asthma Medications Sales by Country (K Units), 2027–2032
Table 43. Latin America Inhaled Asthma Medications Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Inhaled Asthma Medications Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Inhaled Asthma Medications Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Inhaled Asthma Medications Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Inhaled Asthma Medications Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Inhaled Asthma Medications Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Inhaled Asthma Medications Revenue by Country (US$ Million), 2027–2032
Table 50. Global Inhaled Asthma Medications Sales (K Units) by Type (2021–2026)
Table 51. Global Inhaled Asthma Medications Sales (K Units) by Type (2027–2032)
Table 52. Global Inhaled Asthma Medications Sales Market Share by Type (2021–2026)
Table 53. Global Inhaled Asthma Medications Sales Market Share by Type (2027–2032)
Table 54. Global Inhaled Asthma Medications Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Inhaled Asthma Medications Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Inhaled Asthma Medications Revenue Market Share by Type (2021–2026)
Table 57. Global Inhaled Asthma Medications Revenue Market Share by Type (2027–2032)
Table 58. Global Inhaled Asthma Medications Price (US$/Unit) by Type (2021–2026)
Table 59. Global Inhaled Asthma Medications Price (US$/Unit) by Type (2027–2032)
Table 60. Global Inhaled Asthma Medications Sales (K Units) by Application (2021–2026)
Table 61. Global Inhaled Asthma Medications Sales (K Units) by Application (2027–2032)
Table 62. Global Inhaled Asthma Medications Sales Market Share by Application (2021–2026)
Table 63. Global Inhaled Asthma Medications Sales Market Share by Application (2027–2032)
Table 64. Global Inhaled Asthma Medications Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Inhaled Asthma Medications Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Inhaled Asthma Medications Revenue Market Share by Application (2021–2026)
Table 67. Global Inhaled Asthma Medications Revenue Market Share by Application (2027–2032)
Table 68. Global Inhaled Asthma Medications Price (US$/Unit) by Application (2021–2026)
Table 69. Global Inhaled Asthma Medications Price (US$/Unit) by Application (2027–2032)
Table 70. Teva Pharmaceutical Company Information
Table 71. Teva Pharmaceutical Description and Business Overview
Table 72. Teva Pharmaceutical Inhaled Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Teva Pharmaceutical Inhaled Asthma Medications Product
Table 74. Teva Pharmaceutical Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Inhaled Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. GSK Inhaled Asthma Medications Product
Table 79. GSK Recent Developments/Updates
Table 80. Merck Company Information
Table 81. Merck Description and Business Overview
Table 82. Merck Inhaled Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Merck Inhaled Asthma Medications Product
Table 84. Merck Recent Developments/Updates
Table 85. Roche Company Information
Table 86. Roche Description and Business Overview
Table 87. Roche Inhaled Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Roche Inhaled Asthma Medications Product
Table 89. Roche Recent Developments/Updates
Table 90. AstraZeneca Company Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Inhaled Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. AstraZeneca Inhaled Asthma Medications Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. Boehringer Ingelheim International Company Information
Table 96. Boehringer Ingelheim International Description and Business Overview
Table 97. Boehringer Ingelheim International Inhaled Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Boehringer Ingelheim International Inhaled Asthma Medications Product
Table 99. Boehringer Ingelheim International Recent Developments/Updates
Table 100. Sanofi Company Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Inhaled Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Sanofi Inhaled Asthma Medications Product
Table 104. Sanofi Recent Developments/Updates
Table 105. BD Company Information
Table 106. BD Description and Business Overview
Table 107. BD Inhaled Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. BD Inhaled Asthma Medications Product
Table 109. BD Recent Developments/Updates
Table 110. Covis Pharma Company Information
Table 111. Covis Pharma Description and Business Overview
Table 112. Covis Pharma Inhaled Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Covis Pharma Inhaled Asthma Medications Product
Table 114. Covis Pharma Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Inhaled Asthma Medications Distributors List
Table 118. Inhaled Asthma Medications Customers List
Table 119. Inhaled Asthma Medications Market Trends
Table 120. Inhaled Asthma Medications Market Drivers
Table 121. Inhaled Asthma Medications Market Challenges
Table 122. Inhaled Asthma Medications Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Inhaled Asthma Medications
Figure 2. Global Inhaled Asthma Medications Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Inhaled Asthma Medications Market Share by Type: 2025 & 2032
Figure 4. Dry Powder Product Picture
Figure 5. Soft Mist Product Picture
Figure 6. Global Inhaled Asthma Medications Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Inhaled Asthma Medications Market Share by Application: 2025 & 2032
Figure 8. Anti-inflammatory
Figure 9. Bronchodilators
Figure 10. Combination Therapy
Figure 11. Other
Figure 12. Global Inhaled Asthma Medications Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Inhaled Asthma Medications Market Size (US$ Million), 2021–2032
Figure 14. Global Inhaled Asthma Medications Sales (K Units), 2021–2032
Figure 15. Global Inhaled Asthma Medications Average Price (US$/Unit), 2021–2032
Figure 16. Inhaled Asthma Medications Report Years Considered
Figure 17. Inhaled Asthma Medications Sales Share by Manufacturers in 2025
Figure 18. Global Inhaled Asthma Medications Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Inhaled Asthma Medications Players: Market Share by Revenue in Inhaled Asthma Medications in 2025
Figure 20. Inhaled Asthma Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Inhaled Asthma Medications Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Inhaled Asthma Medications Sales Market Share by Country (2021–2032)
Figure 23. North America Inhaled Asthma Medications Revenue Market Share by Country (2021–2032)
Figure 24. United States Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Inhaled Asthma Medications Sales Market Share by Country (2021–2032)
Figure 27. Europe Inhaled Asthma Medications Revenue Market Share by Country (2021–2032)
Figure 28. Germany Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Inhaled Asthma Medications Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Inhaled Asthma Medications Revenue Market Share by Region (2021–2032)
Figure 35. China Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Inhaled Asthma Medications Sales Market Share by Country (2021–2032)
Figure 43. Latin America Inhaled Asthma Medications Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Inhaled Asthma Medications Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Inhaled Asthma Medications Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Inhaled Asthma Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Inhaled Asthma Medications by Type (2021–2032)
Figure 54. Global Revenue Market Share of Inhaled Asthma Medications by Type (2021–2032)
Figure 55. Global Inhaled Asthma Medications Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Inhaled Asthma Medications by Application (2021–2032)
Figure 57. Global Revenue Market Share of Inhaled Asthma Medications by Application (2021–2032)
Figure 58. Global Inhaled Asthma Medications Price (US$/Unit) by Application (2021–2032)
Figure 59. Inhaled Asthma Medications Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
